This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

Teresa Karnatz
Senior Director of Business Development (Europe & UK) at Biocina Pty Ltd
Speaker

Profile

Teresa Karnatz is a Senior Director Business Development Europe & UK at BioCina, a global contract development and manufacturing organization with strategically located manufacturing facilities in Australia, supporting innovative biopharmaceutical companies from early development through clinical manufacturing. Teresa brings more than 15 years of international experience in business development, key account management and strategic partnerships across the pharmaceutical and biopharmaceutical industry, having held key roles at Recipharm and IDT Biologika.

At BioCina, Teresa works closely with biotech and pharmaceutical companies to develop manufacturing strategies and identify the right pathways for advancing clinical programs. Her expertise spans biologics, microbial and plasmid manufacturing, mRNA and LNP programs, as well as sterile drug product and fill-finish.

Based in Europe and working closely with BioCina’s operations in Australia, Teresa brings a valuable cross-market perspective on how Australia’s regulatory environment, clinical ecosystem and manufacturing capabilities can support emerging biopharma companies in efficiently advancing their programs towards First-in-Human studies. She offers particular insight into how Australia’s streamlined regulatory pathways, integrated manufacturing capabilities and attractive R&D tax incentives can support companies looking to efficiently advance promising candidates fast into the clinic.



Agenda Sessions

  • Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic

    , 14:30